NCT05973747View on ClinicalTrials.gov

Pharmacokinetic Equivalence of Calcium Gluconate and Calcium Chloride in Parturients

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

August 19, 2023

Primary Completion Date

December 15, 2023

Study Completion Date

December 15, 2023

Conditions
Postpartum HemorrhagePregnancy RelatedHypocalcemiaParturition Complication
Interventions
DRUG

Calcium Gluconate

Infused intravenously over 10 minutes upon umbilical cord clamping. First 10 assigned patients received 2 grams per protocol. Subsequent 13 patients received 1.5 grams, dose recalibrated per protocol.

DRUG

Calcium chloride

0.5 grams of calcium chloride, infused intravenously over 10 minutes upon umbilical cord clamping

Trial Locations (1)

94305

Lucile Packard Children's Hospital, Stanford

All Listed Sponsors
lead

Stanford University

OTHER